H. Bjørn Nielsen, Ph.D., Chief Scientific Officer at Clinical-Microbiomics A/S, has since 2008 been a frontrunner in the field of microbiome research. His participation in the MetaHit consortium led to a series of important scientific papers
describing the human gut microbiome, including his pioneering work on co-abundance binning of metagenomics data into metagenomic species, and bacteriophages and other mobile genetic elements. This year Henrik has authored 4 papers published in Nature journals, including a three-pronged association study that links microbiome, serum metabolome and clinical data in pre-diabetic Danes, and a study that report on the larges metatranscriptomics to date. At Clinical- Microbiomics, H. Bjørn heads the innovation with clients and the continued adaptation
and development of new analysis concepts and methods.